1Droller MJ. Prostaglandins and neoplasia. J Urol, 1981,125 (6) : 757-760.
2Reiss AB, Edelman SD. Recent insights into the role of prostanoids in atherosclerotic vascular disease. Curr Vase Pharmacol. 2006,4 (4) :395-408.
3Aitokallio-Tallberg A, Karkkainen J, Pantzar P, et al. Prostacyclin and thrombexane in breast cancer:relationship between steroid receptor status and medroxyprogesterone acetate. Br J Cancer, 1985, 51 (5) :671-674.
4Mitsuhashi M, Liu J, Cao S, et al. Regulation of interleukin - 12 gune expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J Leukoc Biol. 2004,76 ( 2 ) : 322-332.
5Shibuya M. Vascular endothelial growth factor-dependent and - independent regulation of angiogenesis. BMB Rep. 2008,41 (4) : 278-286.
7Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 2007,26 ( 3/4 ) : 525- 534.
8Caine GJ,Lip GY,Stonelake PS,et al. Platelet activation,coagulation and angiogenesis in breast and prostate carcinoma. Thromb Haemost,2004,92 ( 1 ) :185-190.
2Wang WH,Wang SB,Yan L,et al.Superoxide production and reactive oxygen species signaling by endothelial nitric oxide synthase.J Biol Chem,2000,275(22):16 899.
3Andrew PJ,Mayer B.Enzymatic function of nitric oxide synthases.Cardiovasc Res,1999,43(3):521.
4Vallet B.Bench-to-bedside review:Endothelial cell dysfunction in severe sepsis:a role in organ dysfunction.Crit care,2003,7(2):130.
